Festive reflections on Med Tech
We are at that reflective time of year so there will be a lot of that in this edition, but also a seasonal gift in the form of our revised roadmap that sets out a more future view. Some of …
We are at that reflective time of year so there will be a lot of that in this edition, but also a seasonal gift in the form of our revised roadmap that sets out a more future view. Some of …
A lot has happened in the month since my last blog, including the launch of the national conversation about the NHS and Budget announcement of additional funding for Life Sciences. This has highlighted the vital role of diagnostics and Med …
Our external engagement on the programme of regulatory changes for medical devices has re-started in earnest this week following the pre-election period and early discussions with new ministers. Bilateral meetings with Trade Associations have begun again, we are speaking at …
Last time I wrote was just before we headed to Washington DC for the 25th Session of the International Medical Device Regulators Forum (IMDRF), hosted by the US Food and Drug Administration (FDA). The first two days were a workshop …
Welcome to the March issue of the Med Tech Regulatory Reform blog series. As the leader of a team which includes many talented female scientists, I am particularly delighted to be publishing this at the start of British Science …
On 9 January 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) published its Roadmap for the delivery of the future regulatory framework for medical devices. In the first of a new blog series, Laura Squire, Med Tech Regulatory Reform …
An official blog of the Medicines and Healthcare products Regulatory Agency (MHRA), providing expert insight on the latest regulatory thinking and all aspects of medicines regulation.